Healthcare
Health tech, medical devices, and healthcare services startups building in Los Angeles.
Series B$134.0MPelage raised a $120 million Series B co-led by ARCH Venture Partners and Google's venture arm GV, with GV's Cathy Friedman appointed board chair.
$106.8MRenovaro revolutionizes cancer and neurology care through early detection, drug discovery, and personalized treatments. AI-powered precision medicine.
Series F$98.3MNeOnc is a clinical-stage life sciences company developing a novel intranasal drug delivery system and platform technology to treat brain cancers and other central nervous system (CNS) diseases by bypassing the Blood-Brain Barrier (BBB).
Series B$85.0MProactive health memberships combining Whole Body MRI, advanced blood biomarker testing, and ongoing clinical guidance—designed to help you track your health year over year.
Series B$84.3MRebuilding healthcare with AI at the core
Series B$20.6MPictor Labs is The Virtual Staining Company enabling digital pathology adoption through computational virtual staining technology that preserves tissue for comprehensive downstream analysis.
Series B$15.2MThe Data Intelligence Network for Healthcare OutcomeMD’s Patient Experience Data Network™ turns de-identified patient-reported outcome measures (PROMs) into act
$4.9MCalifornia Compounding is a trusted compounding partner for telehealth and clinics, offering office stock programs, prescriber portals, and scalable fulfillment.
Series A$4.2MAI-driven medical coding from Synaptec Health - a more accurate, secure, and comprehensive solution for all your medical coding needs.
$3.5MKairos Pharma develops novel therapies to combat cancer drug resistance and restore immune response, advancing innovative treatments for cancer patients.
Does business as Mahmee, a maternal health startup co-founded by Melissa Hanna that raised $3M in seed funding from Mark Cuban and Serena Williams.
Series A$3.0MAmydis is the leader in developing a new class of diagnostic compounds that enable digital detection and monitoring of human disease-related molecular biomarkers through standard ocular imaging cameras.
$2.5MSureCount SmartTrays streamline surgical instrument management, reducing errors, speeding counts, and improving safety across OR and SPD teams.
Series D$2.2MThis entity is tied to Emergency Care Partners, which is majority owned by private-equity firm Varsity Healthcare Partners and received a structured equity investment from MidOcean Partners in 2025.
Seed$1.2MParalos Bioscience, co-founded by Yanxi Yang, is developing a phage-drug conjugate platform targeting drug-resistant infections and has been backed by Carbon Silicon Ventures, Larta Institute, Incate, and UCLA's Magnify program.
BioSig Technologies (Nasdaq: BSGM), originally a medical-device company, pivoted into real-world-asset tokenization through a 2025 merger with Streamex Exchange, backed by mining financier Frank Giustra as a strategic advisor.
Series B$300K
Series A$200K
$35Founded by Dr. Susanne B. Nicholas, a UCLA nephrology professor, to commercialize kidney-disease research from her own lab.
Founded and led by Ilya Rachman, a physician-scientist and former UCLA clinical faculty member; the company trades publicly on Nasdaq under ticker IMMX.
The API for Diagnostic Test Analysis (COVID-19, FLU, RSV, STD,…
Healthcare Price Transparency APIs and Data Products
Scheduling and workforce management SaaS for home healthcare providers
Responsive materials, better lives.
Our mobile app reduces chronic pain for 100 million Americans.
A new way of seeing inside the human body.
Reinventing respiration monitoring